Dec 19, 2023

New tech could modernize recovery from gynecological cancers

Sep 27, 2023

Wave of medical imaging innovation hits shores of Lake Superior

Jun 07, 2023

How Falcons’ Fortunes winner plans to stop colorectal cancer from coming back

Aug 08, 2022

FACIT pitch competition empowers Ontario’s oncology entrepreneurs

Apr 28, 2022

Two OICR innovations bolstered by investments from FACIT

Jun 23, 2020

FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund

Jun 09, 2020

FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)

Nov 06, 2019

FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research

Oct 30, 2019

FACIT and University of Toronto launch precision medicine company: Cellular Analytics

Sep 26, 2019

FACIT's Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies

Jun 18, 2019

From idea to impact: An expanding solution to a common surgical problem

Apr 09, 2019

Entrepreneurs from Ontario's Nanology Labs and Xpan Inc. receive FACIT investment for early-stage cancer innovations 

Mar 27, 2019

The winner of last year’s FACIT Falcons’ Fortunes pitch competition is already seeing early success in moving her product to the clinic

Feb 07, 2019

Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene

Jan 29, 2019

FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy

Jan 29, 2019

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment

Jan 10, 2019

FACIT makes follow-on investment in AI-based genomics company, DNAstack

Oct 11, 2018

FACIT Welcomes Har Grover and Ken Lawless to the Board

Sep 13, 2018

FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants

Aug 22, 2018

Heliotrope: Personalizing cancer treatment decisions

Aug 02, 2018

Ontario centre attracts national attention for probe research, development and commercialization

Jun 27, 2018

Healthcare Software Start-Up Ziliomics Financed by FACIT

Jun 13, 2018

FACIT Appoints Biotech Veteran Dr. David O'Neill as President

Apr 12, 2018

Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition

Feb 21, 2018

FACIT invests $450k in promising Ontario breakthrough technologies

Dec 04, 2017

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Nov 22, 2017

FACIT Welcomes Kevin Empey, Cynthia Goh and Shana Kelley to the Board of Trustees

Oct 04, 2017

FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A

Sep 29, 2017

OICR 2016/17 Annual Report

Aug 01, 2017

FACIT launches cross-border campaign to recruit clinical scientists and biotechnology industry executives

Aug 01, 2017

FACIT announces investment in three Ontario start-ups under Prospects Fund

Mar 22, 2017

FACIT Launches The Prospects Oncology Fund

Mar 22, 2017

FACIT Announces Investment in Propellon Therapeutics

Feb 23, 2017

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Nov 02, 2016

FACIT start-up Turnstone Biologics closes USD $41M financing

Oct 05, 2016

From our Annual Report: Investing in the cure and the economy

Sep 27, 2016

Annual report for the Ontario Institute for Cancer Research

Sep 19, 2016

Open resource: How we’re making our research resources more accessible to the community

Jul 04, 2016

FACIT Falcons’ Fortunes pitch competition helps Ontario ideas take flight

Jun 23, 2016

Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers

Jun 07, 2016

OICR attends BIO International 2016 in San Francisco

May 26, 2016

Privacy Analytics Acquired by IMS Health

Mar 16, 2016

FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic

Jan 28, 2016

Trillium Therapeutics Acquires Fluorinov Pharma

Dec 29, 2015

OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers

Dec 16, 2015

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

Dec 08, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

Dec 08, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

Nov 09, 2015

FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership

Oct 28, 2015

FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management

Jan 07, 2015

Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers